Skip to content

Clinical study on a new program for optimizing intestinal preparation with lactulose

Clinical study on a new program for optimizing intestinal preparation with lactulose

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054318
Enrollment
Unknown
Registered
2021-12-13
Start date
2021-12-31
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:Morning painless colonoscopy preparation program
Group 2:Afternoon painless colonoscopy preparation plan
Group 3:Polyethylene glycol

Sponsors

Drum Tower Hospital Affiliated to Nanjing University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. There are no contraindications for colonoscopy, and it is planned to undergo colonoscopy in the near future. 2. Aged between 18-75 years (including 18, 75 years old, no gender limitation). 3. Voluntarily participate in this clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with other diseases that may affect the judgment of curative effect or have the risk of Jiaotong University, such as: acute stage of inflammatory bowel disease, colon cancer, intussusception, volvulus, intestinal obstruction, peritonitis, ascites, etc.; 2. Patients with serious primary diseases such as lung, liver, kidney, hematopoietic system, mental illness and diabetes; 3. Liver function ALT and AST exceed 1.5 times the upper limit of the reference value, or Cr exceeds the upper limit of the reference value; 4. Those who are suspected or have a history of alcohol or drug abuse; 5. Patients who are pregnant, planning to become pregnant or breastfeeding; 6. Those who have participated in or are participating in other clinical trials within the past 3 months; 7. According to the judgment of the researcher, it is not suitable to participate in this research.

Design outcomes

Primary

MeasureTime frame
Boston gut score;Bubble score;

Secondary

MeasureTime frame
Adverse effect;

Countries

China

Contacts

Public ContactChen Min

Drum Tower Hospital Affiliated to Nanjing University School of Medicine

croweminchan@nju.edu.cn+86 15950479631

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026